UNSPSC 51201621: Tetanus vaccine

This classification denotes a vaccine against a disease caused by tetanospasmin, a powerful protein toxin produced by clostridium tetani, a disease commonly called Tetanus. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.

UNSPSC 51201621 Tetanus vaccine, a Commodity code, captures immunization products that state and local health departments procure for disease prevention and public health programs. The recent activity under this code shows health departments acquiring vaccines to support immunization initiatives, though the most recent opportunity posted under the code does not actually involve tetanus vaccine procurement — the Mississippi State Department of Health posted a sole source notice for yellow fever vaccine from Sanofi Pasteur, Inc., due August 3, 2026. This mismatch between the code's nominal scope and the actual solicitation suggests either a tagging inconsistency in the state procurement database or that the code is being applied more broadly to vaccine acquisition generally rather than tetanus-specific products. State health departments appear to be the primary issuing bodies under this code, acting as the procurement vehicle for immunization programs.

Geographic activity is limited to what the source supports: Mississippi represents the only recent visible opportunity. The Mississippi State Department of Health's yellow fever vaccine notice, posted July 13, 2026, is structured as a sole source procurement requiring objections to be filed with Cynthia Brasher at the department's Purchasing Department by August 3, 2026 at 10:00 a.m. CST. The notice does not specify contract quantity, term, or estimated value. Firms pursuing vaccine opportunities under this code should note that state health departments may invoke sole source authority when they determine a single supplier is available; objection procedures and documentation requirements for demonstrating alternative sources are central to strategy when sole source designations are published.